yingweiwo

Cefalotin

Alias: Cefalotin; Cephalothin; Cephalotin; Cefalothin; Cefalotina; Monosodium Salt, Cephalothin; Normon Brand of Cephalothin Sodium; Salt, Cephalothin Monosodium; Seffin; Sodium Cephalothin; Spaly Brand of Cephalothin Sodium;
Cat No.:V17812 Purity: ≥98%
Cefalotin is a potent cephem antibiotic agent whichinhibits class C β-lactamase AmpC, with an Ki of 0.32 µM.
Cefalotin
Cefalotin Chemical Structure CAS No.: 153-61-7
Product category: Bacterial
This product is for research use only, not for human use. We do not sell to patients.
Size Price Stock Qty
100mg
250mg
500mg
1g
2g
Other Sizes

Other Forms of Cefalotin:

  • Cefalothin sodium
Official Supplier of:
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Top Publications Citing lnvivochem Products
Product Description

Cefalotin is a potent cephem antibiotic agent which inhibits class C β-lactamase AmpC, with an Ki of 0.32 µM. Cefalothin (Cefalotin) is a potent β-lactam cephalosporin antibiotic agent with a wide range antibacterial activity against gram-positive and gram-negative bacteria. It inhibits the growth of various Gram-positive and Gram-negative bacteria, including several strains of S. pyogenes, S. aureus, C. tetani, N. gonorrhoeae, Salmonella, and Shigella.

Biological Activity I Assay Protocols (From Reference)
Targets
β-lactam
ADME/Pharmacokinetics
Absorption, Distribution and Excretion
Cefalotin enters the aqueous humor after subconjunctival injection, reaching peak concentration approximately 1-2 hours post-administration. Within 5 hours of administration, the ratio of aqueous humor to serum antibiotic concentration ranges from 4.0 to 67.0, indicating a biphasic process of antibiotic excretion from the aqueous humor. Studies have shown that… after subcutaneous or oral administration in rats, Cefalotin penetration into bone is very limited. The average concentration ratio of Cefalotin in bone and serum is 1:4… Despite concentration differences, the half-life in bone and serum is similar. Recently discovered drugs that actively cross the human placenta include… Cefalotin… Following administration of 1 gram of Cefalotin, the urinary concentration ranges from 0.7 to 5 mg/mL. Excretion is delayed in cases of decreased renal function… For more complete data on the absorption, distribution, and excretion of Cefalotin (11 species), please visit the HSDB records page.
Metabolism/Metabolites
Cefothiophene is metabolized into less active deacetylated metabolites, but 50-75% of the drug is excreted unchanged in the urine.
Approximately 25% of the administered dose is excreted in the urine as deacetylated Cefalotin.
Cefothiophene…is deacetylated in the body, and these metabolites have lower antibacterial activity than the parent compound…Deacetylated metabolites are also excreted by the kidneys.
Biological Half-Life
30 minutes
Injection half-life = 0.6 hours (Data from table)
Toxicity/Toxicokinetics
Protein Binding
65-80% Interactions Concomitant use with probenecid may prolong the serum half-life of Cefalotin. Animal studies have shown that furosemide enhances the nephrotoxicity of Cefalotin. Cephalosporins may be affected by concomitant use with sulfinpyrazone. Reduced renal tubular secretion of weak acids may lead to higher serum concentrations and longer durations of action, thereby enhancing drug activity. Cephalosporins Nonionic, anionic, and amphoteric surfactants induce a rapid and reversible state of hyperabsorption in the gastric fundus of Thomas dogs…Cefalotin… For more complete data on interactions of Cefalotin (10 in total), please visit the HSDB record page.
Non-human toxicity values
Rats oral LD50 >10,000 mg/kg/sodium salt/
Rats intraperitoneal LD50 7716 mg/kg/sodium salt/
Mice oral LD50 >20,000 mg/kg/sodium salt/
Mice intraperitoneal LD50 5670 mg/kg/sodium salt/
References

[1]. Structure-based optimization of cephalothin-analogue boronic acids as beta-lactamase inhibitors. Bioorg Med Chem. 2008 Feb 1;16(3):1195-205. Epub 2007 Nov 7.

Additional Infomation
Cefalotin is a semi-synthetic first-generation cephalosporin antibiotic with an acetoxymethyl group at position 3 and a (2-thiopheneacetyl)nitrile group at positions 7 of its core structure. It is administered parenterally for use during surgery and to treat various bloodstream infections. It possesses antibacterial and antimicrobial activity. Cefalotin is a semi-synthetic derivative belonging to the β-lactam antibiotic class, allergen, cephalosporin, carboxylic acid, thiophene compound, and azabicyclic olefin. It is the conjugate acid of Cefalotin (1-). Cefalotin is a cephalosporin antibiotic. There are reports of Cefalotin's presence in bovine (Bos taurus) with relevant data. Cefalotin is a semi-synthetic, β-lactam, first-generation cephalosporin antibiotic with bactericidal activity. Cefalotin binds to and inactivates penicillin-binding protein (PBP) located on the inner membrane of the bacterial cell wall. PBP is involved in the final stages of bacterial cell wall assembly and cell wall remodeling during cell division. Inactivation of PBPs interferes with the cross-linking of peptidoglycan chains, which is crucial for maintaining the strength and rigidity of bacterial cell walls. This leads to weakening of the bacterial cell wall, ultimately resulting in cell lysis.
Cephalosporin antibiotics.
Indications
For the prevention of infections during surgery and the treatment of various blood, bone or joint, respiratory, skin, and urinary tract infections.
Mechanism of Action
The bactericidal activity of Cefalotin derives from its affinity for penicillin-binding proteins (PBPs), thereby inhibiting cell wall synthesis. Penicillin-binding proteins (PBPs) are transpeptidases that play a vital role in peptidoglycan biosynthesis. Therefore, inhibiting PBPs prevents the normal synthesis of this important cell wall component.
Cephalosporins have bactericidal activity; their mechanism of action depends on their ability to reach and bind to penicillin-binding proteins located on the bacterial cytoplasmic membrane. Cephalosporins inhibit the synthesis of bacterial septa and cell walls, likely through the action of membrane-bound transpeptidases. This prevents the cross-linking of peptidoglycan chains, which is crucial for the strength and rigidity of bacterial cell walls. Furthermore, cell division and growth are inhibited, and susceptible bacteria frequently elongate and lyse. Rapidly dividing bacteria are most sensitive to cephalosporins. /Cephalosporins/
Therapeutic Uses
Because Cefalotin is the least susceptible to degradation by staphylococcal β-lactamases, it is highly effective against severe staphylococcal infections (such as endocarditis).
MeSH Title: Antimicrobial Agents
Should be limited to treating severe infections caused by susceptible bacteria, most commonly in patients allergic to penicillin. /Sodium/
...Cephalosporins are...the first-line drugs for treating Klebsiella infections...They can be used as an alternative to penicillin. /Cephalosporins/
For more complete data on the therapeutic uses of Cefalotin (28 in total), please visit the HSDB record page.
Drug Warnings
Drug excretion is delayed in cases of decreased renal function; in cases of severe renal failure, the dosing interval must be extended.
Cefothiophene should not be used to treat bacterial meningitis.
Enterococcal infections are generally unaffected by these compounds…Cefosporins cannot cure enterococcal endocarditis, even when used concomitantly with gentamicin or streptomycin. /Cefosporins/
Patients with a history of mild or prolonged responses to penicillin appear to have a lower risk of developing a rash or other allergic reactions after cephalosporin treatment…Cefosporins should be used with caution or avoided in patients with a recent severe immediate-type reaction to penicillin. /Cefosporins/
For more complete data on drug warnings for cephalothiophene (21 in total), please visit the HSDB records page.
Pharmacodynamics
Cefothiophene (INN) or cephalothiophene (USAN) is a semi-synthetic first-generation cephalosporin with broad-spectrum antibacterial activity, administered via the parenteral route.
These protocols are for reference only. InvivoChem does not independently validate these methods.
Physicochemical Properties
Molecular Formula
C16H16N2O6S2
Molecular Weight
396.44
Exact Mass
396.044
Elemental Analysis
C, 48.47; H, 4.07; N, 7.07; O, 24.21; S, 16.18
CAS #
153-61-7
Related CAS #
Cephalothin sodium;58-71-9
PubChem CID
6024
Appearance
White to off-white solid powder
Density
1.6±0.1 g/cm3
Boiling Point
757.2±60.0 °C at 760 mmHg
Melting Point
160-161ºC
Flash Point
411.8±32.9 °C
Vapour Pressure
0.0±2.7 mmHg at 25°C
Index of Refraction
1.676
LogP
1.45
Hydrogen Bond Donor Count
2
Hydrogen Bond Acceptor Count
8
Rotatable Bond Count
7
Heavy Atom Count
26
Complexity
680
Defined Atom Stereocenter Count
2
SMILES
S1C([H])([H])C(C([H])([H])OC(C([H])([H])[H])=O)=C(C(=O)O[H])N2C([C@]([H])([C@@]12[H])N([H])C(C([H])([H])C1=C([H])C([H])=C([H])S1)=O)=O
InChi Key
XIURVHNZVLADCM-IUODEOHRSA-N
InChi Code
InChI=1S/C16H16N2O6S2/c1-8(19)24-6-9-7-26-15-12(14(21)18(15)13(9)16(22)23)17-11(20)5-10-3-2-4-25-10/h2-4,12,15H,5-7H2,1H3,(H,17,20)(H,22,23)/t12-,15-/m1/s1
Chemical Name
(6R,7R)-3-(acetyloxymethyl)-8-oxo-7-[(2-thiophen-2-ylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
Synonyms
Cefalotin; Cephalothin; Cephalotin; Cefalothin; Cefalotina; Monosodium Salt, Cephalothin; Normon Brand of Cephalothin Sodium; Salt, Cephalothin Monosodium; Seffin; Sodium Cephalothin; Spaly Brand of Cephalothin Sodium;
HS Tariff Code
2934.99.9001
Storage

Powder      -20°C    3 years

                     4°C     2 years

In solvent   -80°C    6 months

                  -20°C    1 month

Note: (1). This product requires protection from light (avoid light exposure) during transportation and storage.  (2). Please store this product in a sealed and protected environment (e.g. under nitrogen), avoid exposure to moisture.
Shipping Condition
Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs)
Solubility Data
Solubility (In Vitro)
DMSO : 79~100 mg/mL ( 199.27~252.24 mM)
Solubility (In Vivo)
Solubility in Formulation 1: ≥ 2.5 mg/mL (6.31 mM) (saturation unknown) in 10% DMSO + 40% PEG300 + 5% Tween80 + 45% Saline (add these co-solvents sequentially from left to right, and one by one), clear solution.
For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 25.0 mg/mL clear DMSO stock solution to 400 μL PEG300 and mix evenly; then add 50 μL Tween-80 to the above solution and mix evenly; then add 450 μL normal saline to adjust the volume to 1 mL.
Preparation of saline: Dissolve 0.9 g of sodium chloride in 100 mL ddH₂ O to obtain a clear solution.

Solubility in Formulation 2: ≥ 2.5 mg/mL (6.31 mM) (saturation unknown) in 10% DMSO + 90% (20% SBE-β-CD in Saline) (add these co-solvents sequentially from left to right, and one by one), clear solution.
For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 25.0 mg/mL clear DMSO stock solution to 900 μL of 20% SBE-β-CD physiological saline solution and mix evenly.
Preparation of 20% SBE-β-CD in Saline (4°C,1 week): Dissolve 2 g SBE-β-CD in 10 mL saline to obtain a clear solution.

View More

Solubility in Formulation 3: ≥ 2.5 mg/mL (6.31 mM) (saturation unknown) in 10% DMSO + 90% Corn Oil (add these co-solvents sequentially from left to right, and one by one), clear solution.
For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 25.0 mg/mL clear DMSO stock solution to 900 μL of corn oil and mix evenly.


Solubility in Formulation 4: 10% DMSO+40% PEG300+5% Tween-80+45% Saline: ≥ 2.5 mg/mL (6.31 mM)

 (Please use freshly prepared in vivo formulations for optimal results.)
Preparing Stock Solutions 1 mg 5 mg 10 mg
1 mM 2.5224 mL 12.6122 mL 25.2245 mL
5 mM 0.5045 mL 2.5224 mL 5.0449 mL
10 mM 0.2522 mL 1.2612 mL 2.5224 mL

*Note: Please select an appropriate solvent for the preparation of stock solution based on your experiment needs. For most products, DMSO can be used for preparing stock solutions (e.g. 5 mM, 10 mM, or 20 mM concentration); some products with high aqueous solubility may be dissolved in water directly. Solubility information is available at the above Solubility Data section. Once the stock solution is prepared, aliquot it to routine usage volumes and store at -20°C or -80°C. Avoid repeated freeze and thaw cycles.

Calculator

Molarity Calculator allows you to calculate the mass, volume, and/or concentration required for a solution, as detailed below:

  • Calculate the Mass of a compound required to prepare a solution of known volume and concentration
  • Calculate the Volume of solution required to dissolve a compound of known mass to a desired concentration
  • Calculate the Concentration of a solution resulting from a known mass of compound in a specific volume
An example of molarity calculation using the molarity calculator is shown below:
What is the mass of compound required to make a 10 mM stock solution in 5 ml of DMSO given that the molecular weight of the compound is 350.26 g/mol?
  • Enter 350.26 in the Molecular Weight (MW) box
  • Enter 10 in the Concentration box and choose the correct unit (mM)
  • Enter 5 in the Volume box and choose the correct unit (mL)
  • Click the “Calculate” button
  • The answer of 17.513 mg appears in the Mass box. In a similar way, you may calculate the volume and concentration.

Dilution Calculator allows you to calculate how to dilute a stock solution of known concentrations. For example, you may Enter C1, C2 & V2 to calculate V1, as detailed below:

What volume of a given 10 mM stock solution is required to make 25 ml of a 25 μM solution?
Using the equation C1V1 = C2V2, where C1=10 mM, C2=25 μM, V2=25 ml and V1 is the unknown:
  • Enter 10 into the Concentration (Start) box and choose the correct unit (mM)
  • Enter 25 into the Concentration (End) box and select the correct unit (mM)
  • Enter 25 into the Volume (End) box and choose the correct unit (mL)
  • Click the “Calculate” button
  • The answer of 62.5 μL (0.1 ml) appears in the Volume (Start) box
g/mol

Molecular Weight Calculator allows you to calculate the molar mass and elemental composition of a compound, as detailed below:

Note: Chemical formula is case sensitive: C12H18N3O4  c12h18n3o4
Instructions to calculate molar mass (molecular weight) of a chemical compound:
  • To calculate molar mass of a chemical compound, please enter the chemical/molecular formula and click the “Calculate’ button.
Definitions of molecular mass, molecular weight, molar mass and molar weight:
  • Molecular mass (or molecular weight) is the mass of one molecule of a substance and is expressed in the unified atomic mass units (u). (1 u is equal to 1/12 the mass of one atom of carbon-12)
  • Molar mass (molar weight) is the mass of one mole of a substance and is expressed in g/mol.
/

Reconstitution Calculator allows you to calculate the volume of solvent required to reconstitute your vial.

  • Enter the mass of the reagent and the desired reconstitution concentration as well as the correct units
  • Click the “Calculate” button
  • The answer appears in the Volume (to add to vial) box
In vivo Formulation Calculator (Clear solution)
Step 1: Enter information below (Recommended: An additional animal to make allowance for loss during the experiment)
Step 2: Enter in vivo formulation (This is only a calculator, not the exact formulation for a specific product. Please contact us first if there is no in vivo formulation in the solubility section.)
+
+
+

Calculation results

Working concentration mg/mL;

Method for preparing DMSO stock solution mg drug pre-dissolved in μL DMSO (stock solution concentration mg/mL). Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug.

Method for preparing in vivo formulation:Take μL DMSO stock solution, next add μL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O,mix and clarify.

(1) Please be sure that the solution is clear before the addition of next solvent. Dissolution methods like vortex, ultrasound or warming and heat may be used to aid dissolving.
             (2) Be sure to add the solvent(s) in order.

Biological Data
  • Stereo view of the interactions observed between AmpC and compounds 6–8 in the modelled conformation. [1].Bioorg Med Chem. 2008 Feb 1;16(3):1195-205. Epub 2007 Nov 7.
  • Stereo view of the Active Site Region of the AmpC/8 complex determined to 2.0 Å resolution. (A) The 2Fo – Fc electron density map is shown in blue, contoured at 1.0 σ. [1].Bioorg Med Chem. 2008 Feb 1;16(3):1195-205. Epub 2007 Nov 7.
Contact Us